The Future of Translational Xenobiotic Research In addition to an outstanding scientific program, the meeting provides you with access to state-of-the-art exhibits, ample opportunities to socialize and collaborate with friends and colleagues, and to present your...
Search Results
PBSS: Why All These New Modalities?
Event Topics: Many new drug modalities/platforms have appeared in the recent past, Good targets are hard to find and many are considered “undruggable” Diversity of Modalities expands druggable target space Diversity of Modalities increases probability of technical...
PBSS: Preclinical Development and IND Filing for Small Molecules: Nuts, Bolts and Best Practices
Tumor Models Boston
Come see our VP of Biology and Pharmacology, Yinfei Yin, PhD speak on our new comprehensive platform for PROTAC evaluation. The 12th Annual Tumor Models Boston Summit is the only industry-led meeting uniting 200+ industry experts from pharma, biotech, academic KOLs...